Aardvark Therapeutics Raises $94.2 Million in IPO to Tackle Prader-Willi Syndrome and Obesity with Innovative Drug ARD-101 February 13, 2025
Aardvark Therapeutics Goes Public: Pioneering New Frontiers in Hunger Suppression and Obesity Treatment February 13, 2025
Court Ruling Restores Vital Health Resources After Trump Administration’s Content Removals February 13, 2025
Breaking New Ground: GLP-1 Medications Show Promise in Reducing Alcohol Cravings and Consumption February 12, 2025
Revolutionizing Addiction Treatment: GLP-1 Medications Show Promise in Reducing Alcohol Cravings February 12, 2025
Biopharmaceutical Buzz: Major Acquisitions, Breakthrough Approvals, and Strategic Shifts Shape the Future of Medicine February 12, 2025
Pharmaceutical Power Moves: Merck’s Acquisition Talks, Breakthrough Approvals, and Strategic Shifts in the Industry February 12, 2025
“Biopharmaceutical Buzz: Major Mergers, Milestone Approvals, and Strategic Shifts Reshape the Industry” February 12, 2025
Pharmaceutical Industry on the Move: Strategic Acquisitions, Regulatory Wins, and Innovative Partnerships Shaping the Future February 11, 2025
Merck KGaA’s Acquisition Talks Ignite SpringWorks Surge Amidst Dynamic Biopharmaceutical Landscape February 11, 2025
